| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.09 | 0.1 |